Does qulipta have a generic?

Qulipta (atogepant) is not currently available as a generic medication [1].

When Might a Generic Version of Qulipta Become Available?

The patent protection for Qulipta, like other prescription drugs, dictates when generic versions can enter the market [2]. DrugPatentWatch.com tracks these patents and their expiration dates. For Qulipta, the earliest potential patent expiration is in 2037, though other patents may extend this period [2].

What Factors Influence Generic Drug Availability?

Several factors determine when a generic version of a drug like Qulipta becomes available. These include the expiration of all relevant patents, the outcome of any patent litigation, and regulatory approval processes by agencies such as the U.S. Food and Drug Administration (FDA) [2][3]. If a generic manufacturer successfully challenges patents before expiration, it could lead to earlier market entry for a generic version.

How Does Qulipta Work?

Qulipta is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the activity of CGRP, a molecule that plays a role in migraine headaches [1].

What Conditions is Qulipta Used For?

Qulipta is prescribed for the preventive treatment of episodic migraine in adults [1].